Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index; 213 of the 289 sources its claims cite were checked for support.

ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives

Open access
Bogdańska-Chomczyk, Ewelina, Majewski, Mariusz Krzysztof, Kozłowska, Anna · 2025 · International Journal of Molecular Sciences

Abstract

Attention-deficit/hyperactivity disorder (ADHD) in adults has become an increasingly recognized clinical entity, with growing attention in research and healthcare settings. ADHD can significantly affect multiple domains of adult functioning, including education, employment, interpersonal relationships, and both mental and physical health. However, despite the expanding body of literature, gaps in understanding persist. This narrative review synthesizes current evidence on adult ADHD. The literature was systematically searched in databases such as PubMed, Scopus, and PsycINFO using predefined keywords related to ADHD in adults. Inclusion criteria focused on peer-reviewed articles published between 2010 and 2025, addressing epidemiology, etiology, diagnosis, treatment, and functioning. Exclusion criteria included studies with pediatric populations only or lacking methodological rigor. ADHD in adults is prevalent worldwide, with considerable heterogeneity across studies. Its etiology involves complex interactions between genetic, neurobiological, and environmental factors. Clinical presentation in adulthood differs from childhood, with symptoms such as inattention, emotional dysregulation, and executive dysfunction predominating. Diagnostic challenges include retrospective assessment of childhood symptoms and comorbidity with mood and anxiety disorders. Pharmacotherapy and cognitive–behavioral interventions show efficacy, particularly when combined in integrated care models. ADHD negatively affects quality of life and occupational and social functioning and increases the risk of comorbid disorders, including psychoactive substance use. Adult ADHD is a multifaceted condition requiring a comprehensive, multidisciplinary approach to diagnosis and management. Future research should aim to refine diagnostic tools, explore neurobiological markers, and tailor interventions to individual profiles. Expanding knowledge on adult ADHD will improve identification, treatment outcomes, and overall quality of life for affected individuals.

Overview

CoChat Summary

## TL;DR

This is a narrative review of adult ADHD that synthesizes literature from 2010–2025 on epidemiology, etiology, neurobiology, diagnosis, treatment, and functioning. It concludes that adult ADHD is common, heterogeneous, frequently comorbid, and best managed with integrated pharmacological and psychosocial care.

## Key findings

  • Adult ADHD prevalence is reported as about 3%–6% in adults, with a global estimate of approximately 2.8%; the review also notes a broader range of approximately 2.5%–6.7%.
  • Around 60%–65% of people diagnosed in childhood continue to have symptoms as adults, and many adults are first diagnosed late: in the USA, 55.9% were first diagnosed at age 18 or older, and one clinical/primary care study found only 25% had a childhood diagnosis.
  • Psychiatric comorbidity is very common: 50%–80% of adults with ADHD have at least one additional mental disorder; mood disorders affect about 50%, anxiety disorders 20%–50%, substance use disorders carry a twofold increased risk, and emotional dysregulation is estimated in roughly 34%–70% of adults.
  • Treatment evidence supports stimulants as first-line and most efficacious medications, with non-stimulants also effective; CBT is described as the most validated psychological therapy, with moderate-to-large effects on symptom reduction and comorbid anxiety/depression.
  • Functional impact is substantial: adults with ADHD show lower educational attainment, more employment instability, and in one cross-national survey had 8.4 excess sick days per year.

## Methods

  • Narrative review, not a meta-analysis; the authors systematically searched PubMed, Scopus, Web of Science, and PsycINFO using ADHD-adult-related keywords and Boolean operators.
  • Included peer-reviewed English or Polish articles from 2010–2025 focused on adults (≥18 years) and on epidemiology, etiology, neurobiology, diagnosis, treatment, functioning, or quality of life; excluded pediatric-only studies, non-scientific items, conference abstracts without full text, poor-quality studies, and pre-2010 papers without updated relevance.
  • The analysis was qualitative synthesis with narrative review of themes, with quantitative numbers extracted where applicable.

## Limitations

  • The paper states that it is not a formal meta-analysis, so it cannot provide pooled effect sizes or quantitative comparisons.
  • The included literature is heterogeneous in diagnostic criteria, assessment tools, and sample characteristics, which limits comparability; this is stated in the paper.
  • Much of the evidence relies on retrospective self-report of childhood symptoms, which the paper notes may introduce recall bias.
  • Because the search ended in 2025 and the authors note the possibility of publication bias and exclusion of very recent publications, these are evident limitations from the text.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms262211020

Cites

192 of 192 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Major environmental risk factors and modulators in ADHD.
Figure 1 Major environmental risk factors and modulators in ADHD.CC BY · PubMed Central

Verification

Claims the paper makes

128 Valid · 39 Not valid · 44 Not checked · 82 Own results and interpretations

157 more claims · 84 with their cited sources checked

Create a free account to see all 293 claims and to verify the 7 references still open.

See all claims — free account
  • Probably not a substantial claim. 25
  • It may state two separate claims as one. 119

Create a free account to see these claims.

Citations

Cites

Show all 185 references

Research works printed but not linked: 9

  1. Hrys, 2024, Aдaптaцiйний пoтeнцiaл ociб дopocлoгo вiкy з poзлaдoм дeфiцитy yвaги/гiпepaктивнocтi (PДУГ), Insight Psychol. Dimens. Soc., 12, 471
  2. Takizawa, 2013, Prefrontal activation during inhibitory control measured by near-infrared spectroscopy for differentiating between autism spectrum disorders and attention deficit hyperactivity disorder in adults, Neuroimage Clin., 4, 53
  3. Cubillo, 2006, Executive dysfunctions in adults with attention deficit hyperactivity disorder, Rev. Neurol., 43, 678
  4. 2012, Cognitive and executive functions in ADHD, Actas Esp. Psiquiatr., 40, 293
  5. (2025, August 06). Table 7, DSM-IV to DSM-5 Attention-Deficit/Hyperactivity Disorder Comparison, Available online: https://www.ncbi.nlm.nih.gov/books/NBK519712/table/ch3.t3/.
  6. (2025, August 10). Treatment in adult ADHD|Oxford Textbook of Attention Deficit Hyperactivity Disorder|Oxford Academic. Available online: https://academic.oup.com/book/24517/chapter-abstract/187669990?redirectedFrom=fulltext.
  7. Knecht, 2015, Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder, Neuropsychiatr. Dis. Treat, 11, 1359
  8. Biederman, 2006, The Effects of Attention-Deficit/Hyperactivity Disorder on Employment and Household Income, MedGenMed, 8, 12
  9. 2022, Marital Adjustment and Marital Conflict in Individuals Diagnosed with ADHD and Their Spouses, Noro Psikiyatr Ars, 59, 127

Cited by

See all 15

Metadata

Authors
Bogdańska-Chomczyk, E., Majewski, M. K., & Kozłowska, A.
Affiliations
University of Warmia and Mazury in Olsztyn (PL)
Corresponding author
Kozłowska, Anna
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2025-11-14
Volume
26
Issue
22
Pages
11020
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4416199620
Cited by
15
References
185
Citations by year
2026: 15
FWCI
2.66
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
The Minister of Science under “The Regional Initiative of Excellence Program” (RID/SP/0025/2024/01)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
adult ADHD, attention deficit hyperactivity disorder, comorbidities, mood disorders, anxiety disorders, substance use disorders, executive dysfunction, emotional dysregulation, pharmacotherapy, cognitive behavioral therapy, integrated care, quality of life, occupational functioning, social functioning, etiology, diagnosis
MeSH terms
Adult, Attention Deficit Disorder with Hyperactivity, Humans, Quality of Life, Comorbidity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives. https://app.cochat.ai/papers/10.3390/ijms262211020
The paper
Bogdańska-Chomczyk, E., Majewski, M. K., & Kozłowska, A. (2025). ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.